Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$158.50
-1.5%
$144.41
$55.92
$168.32
$5.09B1.41497,549 shs397,626 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$240.93
+0.1%
$246.70
$166.64
$310.00
$9.38B0.4530,377 shs280,040 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$38.41
-3.0%
$56.97
$37.12
$103.81
$2.14B1.051.56 million shs2.35 million shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€23.50
-2.9%
€24.52
€17.12
€28.00
€7.16B0.55378,447 shs364,300 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.00%-3.92%+17.66%+15.11%+131.39%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%-0.65%-1.15%-18.95%+47.22%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.00%-23.12%-35.13%-27.69%-36.06%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.00%-6.52%-9.55%-1.76%+19.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
1.755 of 5 stars
2.53.00.00.03.10.80.6
Penumbra, Inc. stock logo
PEN
Penumbra
4.6479 of 5 stars
3.54.00.03.72.82.51.9
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
3.4095 of 5 stars
4.41.00.00.03.03.30.6
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
3.00
Buy$157.30-0.76% Downside
Penumbra, Inc. stock logo
PEN
Penumbra
2.94
Moderate Buy$300.4724.71% Upside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.78
Moderate Buy$74.8894.94% Upside
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
2.83
Moderate BuyN/AN/A

Current Analyst Ratings Breakdown

Latest PRCT, PEN, STVN, and IRTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$75.00 ➝ $58.00
8/7/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$80.00 ➝ $55.00
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$145.00 ➝ $190.00
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$139.00 ➝ $170.00
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$130.00 ➝ $180.00
8/1/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$151.00 ➝ $180.00
7/31/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$260.00 ➝ $266.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$300.00 ➝ $310.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$330.00 ➝ $325.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$330.00 ➝ $335.00
(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$591.84M8.60N/AN/A$2.90 per share54.66
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B7.87$2.89 per share83.31$29.99 per share8.03
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$224.50M9.52N/AN/A$7.71 per share4.98
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€1.19B5.96€0.75 per share31.30€5.02 per share4.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$113.29M-$2.93N/AN/AN/A-14.06%-90.03%-8.52%10/29/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$3.7664.0848.092.1611.54%11.55%8.76%10/29/2025 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$91.41M-$1.55N/AN/AN/A-30.60%-23.73%-17.34%10/27/2025 (Estimated)
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€127.45M€0.5443.5240.522.2311.73%10.34%6.21%N/A

Latest PRCT, PEN, STVN, and IRTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.41-$0.35+$0.06-$0.35$75.67 million$79.18 million
7/31/2025Q2 2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.53-$0.32+$0.21-$0.44$173.94 million$186.69 million
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81$0.86+$0.05$1.15$327.37 million$339.46 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/A1 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
6.25
5.02
4.88
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.75
4.04
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.13
9.21
7.86
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.25
1.79
1.22

Institutional Ownership

CompanyInstitutional Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A

Insider Ownership

CompanyInsider Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.68%
Penumbra, Inc. stock logo
PEN
Penumbra
5.00%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
17.40%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,00032.13 million31.91 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50039.00 million37.05 millionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43055.64 million45.96 millionOptionable
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
5,521302.84 millionN/AOptionable

Recent News About These Companies

William Blair Cuts Earnings Estimates for Stevanato Group
Brokers Set Expectations for Stevanato Group Q3 Earnings
William Blair Predicts Stronger Earnings for Stevanato Group

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$158.50 -2.49 (-1.55%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$158.42 -0.08 (-0.05%)
As of 08/8/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Penumbra stock logo

Penumbra NYSE:PEN

$240.93 +0.19 (+0.08%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$240.17 -0.76 (-0.32%)
As of 08/8/2025 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$38.41 -1.18 (-2.98%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$38.56 +0.15 (+0.38%)
As of 08/8/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Stevanato Group stock logo

Stevanato Group NYSE:STVN

€23.50 -0.70 (-2.89%)
As of 08/8/2025 03:58 PM Eastern

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.